135 related articles for article (PubMed ID: 37759276)
1. No evidence for neuronal damage or astrocytic activation in cerebrospinal fluid of Neuro-COVID-19 patients with long-term persistent headache.
de Boni L; Odainic A; Gancarczyk N; Kaluza L; Strassburg CP; Kersting XAK; Wüllner U; Schmidt SV; Petzold GC
Neurol Res Pract; 2023 Sep; 5(1):49. PubMed ID: 37759276
[TBL] [Abstract][Full Text] [Related]
2. No serological evidence for neuronal damage or reactive gliosis in neuro-COVID-19 patients with long-term persistent headache.
de Boni L; Odainic A; Gancarczyk N; Kaluza L; Strassburg CP; Kersting XAK; Johnson JM; Wüllner U; Schmidt SV; Nattermann J; Petzold GC
Neurol Res Pract; 2022 Oct; 4(1):53. PubMed ID: 36310154
[TBL] [Abstract][Full Text] [Related]
3. Biomarkers for central nervous system injury in cerebrospinal fluid are elevated in COVID-19 and associated with neurological symptoms and disease severity.
Virhammar J; Nääs A; Fällmar D; Cunningham JL; Klang A; Ashton NJ; Jackmann S; Westman G; Frithiof R; Blennow K; Zetterberg H; Kumlien E; Rostami E
Eur J Neurol; 2021 Oct; 28(10):3324-3331. PubMed ID: 33369818
[TBL] [Abstract][Full Text] [Related]
4. Transient Changes in the Plasma of Astrocytic and Neuronal Injury Biomarkers in COVID-19 Patients without Neurological Syndromes.
Lennol MP; Ashton NJ; Moreno-Pérez O; García-Ayllón MS; Ramos-Rincon JM; Andrés M; León-Ramírez JM; Boix V; Gil J; Blennow K; Merino E; Zetterberg H; Sáez-Valero J
Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769057
[TBL] [Abstract][Full Text] [Related]
5. High Levels of NfL, GFAP, TAU, and UCH-L1 as Potential Predictor Biomarkers of Severity and Lethality in Acute COVID-19.
Salvio AL; Fernandes RA; Ferreira HFA; Duarte LA; Gutman EG; Raposo-Vedovi JV; Filho CHFR; da Costa Nunes Pimentel Coelho WL; Passos GF; Andraus MEC; da Costa Gonçalves JP; Cavalcanti MG; Amaro MP; Kader R; de Andrade Medronho R; Figueiredo CP; Amado-Leon LA; Alves-Leon SV
Mol Neurobiol; 2024 Jun; 61(6):3545-3558. PubMed ID: 37996731
[TBL] [Abstract][Full Text] [Related]
6. Cerebrospinal fluid markers of neuronal and glial cell damage to monitor disease activity and predict long-term outcome in patients with autoimmune encephalitis.
Constantinescu R; Krýsl D; Bergquist F; Andrén K; Malmeström C; Asztély F; Axelsson M; Menachem EB; Blennow K; Rosengren L; Zetterberg H
Eur J Neurol; 2016 Apr; 23(4):796-806. PubMed ID: 26822123
[TBL] [Abstract][Full Text] [Related]
7. Neurochemical signs of astrocytic and neuronal injury in acute COVID-19 normalizes during long-term follow-up.
Kanberg N; Simrén J; Edén A; Andersson LM; Nilsson S; Ashton NJ; Sundvall PD; Nellgård B; Blennow K; Zetterberg H; Gisslén M
EBioMedicine; 2021 Aug; 70():103512. PubMed ID: 34333238
[TBL] [Abstract][Full Text] [Related]
8. Serum and cerebrospinal fluid biomarker profiles in acute SARS-CoV-2-associated neurological syndromes.
Paterson RW; Benjamin LA; Mehta PR; Brown RL; Athauda D; Ashton NJ; Leckey CA; Ziff OJ; Heaney J; Heslegrave AJ; Benedet AL; Blennow K; Checkley AM; Houlihan CF; Mummery CJ; Lunn MP; Manji H; Zandi MS; Keddie S; Chou M; Vinayan Changaradil D; Solomon T; Keshavan A; Barker S; Jäger HR; Carletti F; Simister R; Werring DJ; Spyer MJ; Nastouli E; Gauthier S; Rosa-Neto P; ; Zetterberg H; Schott JM
Brain Commun; 2021; 3(3):fcab099. PubMed ID: 34396099
[TBL] [Abstract][Full Text] [Related]
9. Biomarkers of Neurological Damage: From Acute Stage to Post-Acute Sequelae of COVID-19.
Zingaropoli MA; Pasculli P; Barbato C; Petrella C; Fiore M; Dominelli F; Latronico T; Ciccone F; Antonacci M; Liuzzi GM; Talarico G; Bruno G; Galardo G; Pugliese F; Lichtner M; Mastroianni CM; Minni A; Ciardi MR
Cells; 2023 Sep; 12(18):. PubMed ID: 37759493
[No Abstract] [Full Text] [Related]
10. Evaluation of cerebrospinal fluid ubiquitin C-terminal hydrolase-L1, glial fibrillary acidic protein, and neurofilament light protein as novel markers for the diagnosis of neurosyphilis among HIV-negative patients.
Chen R; Lin LR; Xiao Y; Ke WJ; Yang TC
Int J Infect Dis; 2023 Feb; 127():36-44. PubMed ID: 36400375
[TBL] [Abstract][Full Text] [Related]
11. Cerebrospinal fluid levels of GFAP and pNF-H are elevated in patients with chronic spinal cord injury and neurological deterioration.
Holmström U; Tsitsopoulos PP; Holtz A; Salci K; Shaw G; Mondello S; Marklund N
Acta Neurochir (Wien); 2020 Sep; 162(9):2075-2086. PubMed ID: 32588294
[TBL] [Abstract][Full Text] [Related]
12. Serum and cerebrospinal fluid brain damage markers neurofilament light and glial fibrillary acidic protein correlate with tick-borne encephalitis disease severity-a multicentre study on Lithuanian and Swedish patients.
Veje M; Griška V; Pakalnienė J; Mickienė A; Bremell D; Zetterberg H; Blennow K; Lindquist L; Studahl M
Eur J Neurol; 2023 Oct; 30(10):3182-3189. PubMed ID: 37431060
[TBL] [Abstract][Full Text] [Related]
13. A pharmacokinetic and biomarker study of delayed-release dimethyl fumarate in subjects with secondary progressive multiple sclerosis: evaluation of cerebrospinal fluid penetration and the effects on exploratory biomarkers.
Edwards KR; Kamath A; Button J; Kamath V; Mendoza JP; Zhu B; Plavina T; Woodward C; Penner N
Mult Scler Relat Disord; 2021 Jun; 51():102861. PubMed ID: 33773271
[TBL] [Abstract][Full Text] [Related]
14. Blood neurofilament light chain and total tau levels at admission predict death in COVID-19 patients.
De Lorenzo R; Loré NI; Finardi A; Mandelli A; Cirillo DM; Tresoldi C; Benedetti F; Ciceri F; Rovere-Querini P; Comi G; Filippi M; Manfredi AA; Furlan R
J Neurol; 2021 Dec; 268(12):4436-4442. PubMed ID: 33973106
[TBL] [Abstract][Full Text] [Related]
15. Cerebrospinal fluid findings in neurological diseases associated with COVID-19 and insights into mechanisms of disease development.
Espíndola OM; Brandão CO; Gomes YCP; Siqueira M; Soares CN; Lima MASD; Leite ACCB; Torezani G; Araujo AQC; Silva MTT
Int J Infect Dis; 2021 Jan; 102():155-162. PubMed ID: 33127503
[TBL] [Abstract][Full Text] [Related]
16. Acute Temporal Profiles of Serum Levels of UCH-L1 and GFAP and Relationships to Neuronal and Astroglial Pathology following Traumatic Brain Injury in Rats.
Huang XJ; Glushakova O; Mondello S; Van K; Hayes RL; Lyeth BG
J Neurotrauma; 2015 Aug; 32(16):1179-89. PubMed ID: 25763798
[TBL] [Abstract][Full Text] [Related]
17. Serum Tau, Neurofilament Light Chain, Glial Fibrillary Acidic Protein, and Ubiquitin Carboxyl-Terminal Hydrolase L1 Are Associated with the Chronic Deterioration of Neurobehavioral Symptoms after Traumatic Brain Injury.
Lange RT; Lippa S; Brickell TA; Gill J; French LM
J Neurotrauma; 2023 Mar; 40(5-6):482-492. PubMed ID: 36170576
[TBL] [Abstract][Full Text] [Related]
18. Glial and neuroaxonal biomarkers in a multiple sclerosis (MS) cohort.
Kalatha T; Hatzifilippou E; Arnaoutoglou M; Balogiannis S; Koutsouraki E
Hell J Nucl Med; 2019; 22 Suppl 2():113-121. PubMed ID: 31802051
[TBL] [Abstract][Full Text] [Related]
19. Serum tau protein elevation in migraine: a cross-sectional case-control study.
Overeem LH; Raffaelli B; Fleischmann R; Süße M; Vogelgesang A; Maceski AM; Papadopoulou A; Ruprecht K; Su W; Koch M; Siebert A; Arkuszewski M; Tenenbaum N; Kuhle J; Reuter U
J Headache Pain; 2023 Sep; 24(1):130. PubMed ID: 37726712
[TBL] [Abstract][Full Text] [Related]
20. Cognitive impairment without altered levels of cerebrospinal fluid biomarkers in patients with encephalitis caused by varicella-zoster virus: a pilot study.
Eckerström M; Nilsson S; Zetterberg H; Blennow K; Grahn A
Sci Rep; 2020 Dec; 10(1):22400. PubMed ID: 33372192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
